A 5‐gene breast cancer panel including BRCA1, BRCA2, and TP53 was ordered because of a family history of a sister with duodenal leimyosarcoma at age 44 and a father with lung cancer at age 70 (Fig. 2). This evidence concerns the gene BRCA2 and breast carcinoma.